The National Law Review22d
C3i Center, a Canadian company, receives approval from the EMA to manufacture cell therapy products for the European market
Here is a quote from Yvan Côté, CEO of C3i: “As a Canadian CDMO, we're proud to offer innovative solutions to the challenges of biomanufacturing and commercializing treatments that change lives.
GEN22d
C3i Center Receives EMA Approval to Manufacture Cell Therapy Products for Europe
Last year, C3i became the first CDMO for cell and gene ... “As a Canadian CDMO, we’re proud to offer innovative solutions to the challenges of biomanufacturing and commercializing treatments ...
Canadian Manufacturing22d
C3i to manufacture cell therapy products for European market
Yvan Côté, CEO of C3i, said, “As a Canadian CDMO, we’re proud to offer innovative solutions to the challenges of biomanufacturing and commercializing treatments that change lives.
Kauppalehti22d
C3i Center, a Canadian company, receives approval from the EMA to manufacture cell therapy products for the European market
Here is a quote from Yvan Côté, CEO of C3i: “As a Canadian CDMO, we're proud to offer innovative solutions to the challenges of biomanufacturing and commercializing treatments that change lives. Our ...
Toronto Star22d
C3i Center, a Canadian company, receives approval from the EMA to manufacture cell therapy products for the European market
MONTRÉAL, Feb. 19, 2025 (GLOBE NEWSWIRE) — C3i Center (C3i) announces that it has obtained regulatory approval from the EMA (European Medicine Agency) to produce cell therapy treatments for the ...